PL1923463T3 - Peptyd antygenowy do odrzucania raka pochodzący z glipikan-3 (GPC3) do zastosowania u HLA-A2-pozytywnego pacjenta i środek farmaceutyczny zawierający antygen - Google Patents
Peptyd antygenowy do odrzucania raka pochodzący z glipikan-3 (GPC3) do zastosowania u HLA-A2-pozytywnego pacjenta i środek farmaceutyczny zawierający antygenInfo
- Publication number
- PL1923463T3 PL1923463T3 PL06796310T PL06796310T PL1923463T3 PL 1923463 T3 PL1923463 T3 PL 1923463T3 PL 06796310 T PL06796310 T PL 06796310T PL 06796310 T PL06796310 T PL 06796310T PL 1923463 T3 PL1923463 T3 PL 1923463T3
- Authority
- PL
- Poland
- Prior art keywords
- antigen
- gpc3
- glypican
- hla
- cancer
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 2
- 102000036639 antigens Human genes 0.000 title 2
- 108091007433 antigens Proteins 0.000 title 2
- 102000010956 Glypican Human genes 0.000 title 1
- 108050001154 Glypican Proteins 0.000 title 1
- 108050007237 Glypican-3 Proteins 0.000 title 1
- 102000025850 HLA-A2 Antigen Human genes 0.000 title 1
- 108010074032 HLA-A2 Antigen Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4725—Proteoglycans, e.g. aggreccan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005230702 | 2005-08-09 | ||
| PCT/JP2006/315631 WO2007018199A1 (ja) | 2005-08-09 | 2006-08-08 | HLA-A2陽性者用glypican-3(GPC3)由来癌拒絶抗原ペプチド及びこれを含む医薬 |
| EP06796310A EP1923463B1 (en) | 2005-08-09 | 2006-08-08 | Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1923463T3 true PL1923463T3 (pl) | 2012-02-29 |
Family
ID=37727382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06796310T PL1923463T3 (pl) | 2005-08-09 | 2006-08-08 | Peptyd antygenowy do odrzucania raka pochodzący z glipikan-3 (GPC3) do zastosowania u HLA-A2-pozytywnego pacjenta i środek farmaceutyczny zawierający antygen |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8053556B2 (pl) |
| EP (1) | EP1923463B1 (pl) |
| JP (1) | JP5299942B2 (pl) |
| KR (1) | KR101304243B1 (pl) |
| CN (3) | CN103242428B (pl) |
| AU (1) | AU2006277295B2 (pl) |
| CA (1) | CA2619443C (pl) |
| ES (1) | ES2373055T3 (pl) |
| IL (1) | IL189389A (pl) |
| PL (1) | PL1923463T3 (pl) |
| PT (1) | PT1923463E (pl) |
| RU (1) | RU2395519C2 (pl) |
| WO (1) | WO2007018199A1 (pl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006277295B2 (en) | 2005-08-09 | 2011-08-11 | Oncotherapy Science, Inc. | Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| ES2365077T3 (es) | 2006-06-16 | 2011-09-21 | Onco Therapy Science, Inc. | Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo. |
| TWI615403B (zh) * | 2007-02-21 | 2018-02-21 | 腫瘤療法 科學股份有限公司 | 表現腫瘤相關抗原之癌症的胜肽疫苗 |
| US20130217122A1 (en) * | 2012-02-21 | 2013-08-22 | The Trustees Of The University Of Pennsylvania | Expansion of Interferon-Gamma-Producing T-Cells Using Glypican-3 Peptide Library |
| KR20140138900A (ko) | 2012-03-09 | 2014-12-04 | 온코세라피 사이언스 가부시키가이샤 | 펩티드를 포함한 의약 조성물 |
| JP2015533473A (ja) * | 2012-07-12 | 2015-11-26 | ペルシミューン，インコーポレイテッド | 個別のがんワクチン及び適応免疫細胞療法 |
| WO2016049459A1 (en) * | 2014-09-26 | 2016-03-31 | Baylor College Of Medicine | Glypican-3 specific chimeric antigen receptors for adoptive immunotherapy |
| DK3205661T3 (da) | 2014-10-07 | 2021-08-02 | Cytlimic Inc | Hsp70-afledt immunitetsinducerende peptid |
| TW201636358A (zh) * | 2014-12-09 | 2016-10-16 | 腫瘤療法 科學股份有限公司 | 對於ｔｈ１細胞之ｇｐｃ３抗原決定位胜肽及含此之疫苗 |
| CN107428815B (zh) | 2015-03-09 | 2021-07-09 | Cytlimic公司 | 源于gpc3的肽、使用其的用于治疗或预防癌症的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法 |
| CN107530410B (zh) | 2015-03-18 | 2021-11-09 | 欧姆尼赛特有限公司 | 包含经修饰的α病毒表面糖蛋白与肿瘤相关抗原的融合蛋白及其方法 |
| DK3281641T3 (da) | 2015-04-07 | 2021-01-18 | Cytlimic Inc | Adjuvans til cancervacciner |
| BR112017020961A2 (pt) * | 2015-05-18 | 2018-07-10 | Pieris Pharmaceuticals Gmbh | muteína, molécula de ácido nucleico, célula hospedeira, método de produção de uma muteína e método de ligação |
| WO2018070069A1 (ja) | 2016-10-11 | 2018-04-19 | サイトリミック株式会社 | 医薬 |
| JP2018093823A (ja) | 2016-12-15 | 2018-06-21 | Ｈｅａｒｔｓｅｅｄ株式会社 | 未分化幹細胞除去剤及び未分化幹細胞除去方法 |
| CN106822861A (zh) * | 2017-01-12 | 2017-06-13 | 中国人民解放军第二军医大学 | 抗原肽gpc3‑1和gpc3‑3在制备治疗肝癌药物中的应用 |
| TW201835100A (zh) * | 2017-02-06 | 2018-10-01 | 國立研究開發法人國立癌症研究中心 | 新穎ｔ細胞受體 |
| JP2020517259A (ja) | 2017-04-19 | 2020-06-18 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 操作された抗原受容体を発現する免疫細胞 |
| CN108144071B (zh) * | 2017-12-13 | 2021-05-18 | 中国医学科学院肿瘤医院 | 原发性肝癌磁共振双靶点特异性分子探针及其制备方法 |
| JP7273421B2 (ja) | 2018-02-21 | 2023-05-15 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用 |
| WO2023224096A1 (ja) * | 2022-05-18 | 2023-11-23 | 国立研究開発法人国立がん研究センター | 共通がん抗原カクテルを利用した、がんワクチン、ｔｃｒ／ｃａｒ－ｔ細胞治療薬、コンパニオン診断方法、および血中循環がん細胞検出によるがんの発症リスク診断方法 |
| WO2024227447A1 (en) * | 2023-05-03 | 2024-11-07 | Immunoracle Inc. | Compositions and methods of analyzing a sample for antigen-specific immune cells |
| CN118909052B (zh) * | 2024-09-23 | 2024-12-20 | 湖南中晟全肽生物科技股份有限公司 | 一种靶向gpc3的多肽及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554506A (en) * | 1994-03-24 | 1996-09-10 | Ludwig Institute For Cancer Research | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| WO1998058951A1 (en) * | 1997-06-23 | 1998-12-30 | Ludwig Institute For Cancer Research | Isolated nona- and decapeptides which bind to hla molecules, and the use thereof |
| AU2422999A (en) * | 1998-01-27 | 1999-08-09 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | New members of the glypican gene family |
| CA2395926A1 (en) * | 1999-12-28 | 2001-07-05 | Curagen Corporation | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| CN1280307C (zh) * | 2001-04-03 | 2006-10-18 | 宝生物工程株式会社 | 细胞毒性t淋巴细胞 |
| WO2004022597A1 (ja) | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | Gpc3の血中可溶化ｎ端ﾍﾟﾌﾟﾁﾄﾞに対する抗体 |
| WO2004018667A1 (ja) | 2002-08-26 | 2004-03-04 | Kirin Beer Kabushiki Kaisha | ペプチド及びこれを含む医薬 |
| AU2002330482A1 (en) * | 2002-09-04 | 2004-03-29 | Perseus Proteomics Inc. | Method of diagnosing cancer by detecting gpc3 |
| WO2004048938A2 (en) * | 2002-11-26 | 2004-06-10 | Protein Design Labs, Inc. | Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators |
| US7303914B2 (en) * | 2003-01-30 | 2007-12-04 | Hongyang Wang | Monoclonal antibody against human hepatoma and use thereof |
| JP4336898B2 (ja) * | 2003-10-29 | 2009-09-30 | 財団法人くまもとテクノ産業財団 | 悪性黒色腫（メラノーマ）の診断剤 |
| WO2006043362A1 (ja) | 2004-10-19 | 2006-04-27 | Kumamoto University | 悪性黒色腫（メラノーマ）の新規な診断キット |
| AU2006277295B2 (en) | 2005-08-09 | 2011-08-11 | Oncotherapy Science, Inc. | Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
| ES2365077T3 (es) | 2006-06-16 | 2011-09-21 | Onco Therapy Science, Inc. | Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo. |
-
2006
- 2006-08-08 AU AU2006277295A patent/AU2006277295B2/en not_active Ceased
- 2006-08-08 RU RU2008109015/13A patent/RU2395519C2/ru active
- 2006-08-08 KR KR1020087005067A patent/KR101304243B1/ko not_active Expired - Fee Related
- 2006-08-08 CA CA2619443A patent/CA2619443C/en active Active
- 2006-08-08 ES ES06796310T patent/ES2373055T3/es active Active
- 2006-08-08 PT PT06796310T patent/PT1923463E/pt unknown
- 2006-08-08 CN CN201310064285.0A patent/CN103242428B/zh active Active
- 2006-08-08 US US12/063,165 patent/US8053556B2/en active Active
- 2006-08-08 CN CN201510101092.7A patent/CN104877008B/zh active Active
- 2006-08-08 EP EP06796310A patent/EP1923463B1/en active Active
- 2006-08-08 PL PL06796310T patent/PL1923463T3/pl unknown
- 2006-08-08 WO PCT/JP2006/315631 patent/WO2007018199A1/ja not_active Ceased
- 2006-08-08 JP JP2007529588A patent/JP5299942B2/ja active Active
- 2006-08-08 CN CN2006800374198A patent/CN101313063B/zh active Active
-
2008
- 2008-02-07 IL IL189389A patent/IL189389A/en active IP Right Grant
-
2011
- 2011-09-23 US US13/242,019 patent/US8535942B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080056153A (ko) | 2008-06-20 |
| EP1923463A4 (en) | 2009-09-09 |
| US20120040452A1 (en) | 2012-02-16 |
| JPWO2007018199A1 (ja) | 2009-02-19 |
| CA2619443A1 (en) | 2007-02-15 |
| WO2007018199A1 (ja) | 2007-02-15 |
| US20090239806A1 (en) | 2009-09-24 |
| CA2619443C (en) | 2014-07-08 |
| US8535942B2 (en) | 2013-09-17 |
| EP1923463B1 (en) | 2011-10-05 |
| RU2395519C2 (ru) | 2010-07-27 |
| IL189389A (en) | 2011-11-30 |
| CN104877008A (zh) | 2015-09-02 |
| PT1923463E (pt) | 2011-11-24 |
| AU2006277295B2 (en) | 2011-08-11 |
| EP1923463A1 (en) | 2008-05-21 |
| JP5299942B2 (ja) | 2013-09-25 |
| ES2373055T3 (es) | 2012-01-31 |
| US8053556B2 (en) | 2011-11-08 |
| CN101313063A (zh) | 2008-11-26 |
| IL189389A0 (en) | 2008-06-05 |
| CN103242428A (zh) | 2013-08-14 |
| CN101313063B (zh) | 2013-04-03 |
| HK1118079A1 (en) | 2009-01-30 |
| CN104877008B (zh) | 2018-06-05 |
| KR101304243B1 (ko) | 2013-09-05 |
| CN103242428B (zh) | 2015-04-15 |
| AU2006277295A1 (en) | 2007-02-15 |
| RU2008109015A (ru) | 2009-09-20 |
| BRPI0614590A2 (pt) | 2013-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1923463T3 (pl) | Peptyd antygenowy do odrzucania raka pochodzący z glipikan-3 (GPC3) do zastosowania u HLA-A2-pozytywnego pacjenta i środek farmaceutyczny zawierający antygen | |
| IL261346A (en) | Tissue protective peptides and their uses | |
| EP1751179A4 (en) | PEPTIDES DERIVED FROM THE CASEIN AND THEIR THERAPEUTIC USES | |
| IL188019A0 (en) | Novel peptides for use in the treatment of obesity | |
| EP1741783A4 (en) | HUMAN ANTIAMYLOID BETA PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF | |
| EP2102355A4 (en) | PROTEINS AND PEPTIDES WITH EXTENDED ACTION AND METHODS OF PRODUCTION AND USE THEREOF | |
| EG26619A (en) | PEG-quadrangle arbor polymer for binding to proteins and peptides | |
| IL203898A0 (en) | Cdca1 peptide and pharmaceutical agent comprising the same | |
| IL191152A0 (en) | Polypeptide films and methods | |
| PL2010572T3 (pl) | Białka fuzyjne zawierające polipeptydy HPV i peptydy wzmagające odporność do leczenia i zapobiegania rakowi szyjki macicy | |
| IL188153A0 (en) | Supravalent peptide compounds and processor for the preparation thereof | |
| PL1890720T3 (pl) | Kompozycje farmaceutyczne zawierające peptydy pochodzące z kazeiny i sposoby ich stosowania | |
| EP1893233A4 (en) | PEPTIDES AND THERAPEUTIC VACCINES | |
| ZA200801874B (en) | Antigenic peptides and their use | |
| GB0427267D0 (en) | Peptide adjuvants | |
| EP1981704A4 (en) | DEVICE AND METHODS FOR PREPARING SAMPLES OF PEPTIDES AND PROTEINS FROM A SOLUTION | |
| GB0402129D0 (en) | Therapeutic and diagnostic peptides | |
| ZA200800566B (en) | Therapeutic peptides and vaccines | |
| ZA200710374B (en) | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof | |
| GB0521490D0 (en) | RFamide-related peptide precursor proteins and RFamide peptides | |
| GB0503093D0 (en) | Ricin-binding peptide and methods for use thereof | |
| IL177768A0 (en) | Casein derived peptides and therapeutic uses thereof | |
| GB0418156D0 (en) | RFamide-related peptide precursor proteins and RFamide peptides | |
| EP1881843A4 (en) | KINASEPEPTIDES AND ANTIBODIES | |
| IL222485A (en) | Medical preparations that contain peptide-derived peptides and methods for their use |